BOSTON - Allarity Therapeutics, Inc. (NASDAQ: ALLR), a micro-cap biopharmaceutical company valued at $4.79 million, has announced a new protocol for its ongoing clinical trial of stenoparib, a ...

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new ...

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other cancers as well.

Dec. 5, 2024 — Improvements in cancer prevention and screening have averted more deaths from five cancer types combined over the past 45 years than treatment ... Cervical Cancer Deaths in Young ...

A mathematical modeling study conducted in Germany suggests that ovarian cancer incidence could be reduced and health care ...

For a person who loved to hike; do aerobic exercises with Billy Blanks, Gilead, Denise Austin and Jane Fonda every day (I ...

Ovarian cancer is caused by a harmful overgrowth of cells in and around the ovaries. The cancer can start in the lining of the ovary or fallopian tube, the supportive tissue, or in the egg cell. There ...

That’s when the same type of cancer comes back after you have completed treatment and gone into remission. But some cancers, such as ovarian cancer, also raise your risk for developing a ...

A ketogenic diet may have health benefits for the treatment or prevention of cancer. But research is mixed, and it can have downsides for people receiving ongoing cancer treatment. Cancer is most ...

The stage of melanoma skin cancer tells you how thick it is and how far it has spread. Doctors use different systems to stage melanoma. These include the TNM system and number staging system. The ...

Lung cancer survival without treatment is shorter than survival with treatment. People with untreated non-small cell lung cancer—the most common type—typically live between five and 12 months after ...

Verzenio is a CDK4/CDK6 inhibitor which helps slow down the growth of cancer in women with HR-positive ... including pre-/perimenopausal women when used in combination with ovarian suppression The FDA ...